{
    "N/R/U": null,
    "Applicant": "Genzyme Corporation",
    "BLA Number": "103948",
    "Proprietary Name": "Campath ",
    "Proper Name": "alemtuzumab",
    "BLA Type": "351(a)",
    "Strength": "30MG/1ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "October 12, 2004",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "5034",
    "Submission Type": "Supplement",
    "License Number": "1596",
    "Product Number": "003",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "May 07, 2008"
}